• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Does Cannabis Legalization Increase the Risk of Driving-Related Injury?
Research Update

Does Cannabis Legalization Increase the Risk of Driving-Related Injury?

July 1, 2024
Garrett Rossi, MD.
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

Garrett Rossi, MD. Dr. Rossi has no financial relationships with companies related to this material.

REVIEW OF: Brubacher JR et al, N Engl J Med 2022;386(2):148–156

STUDY TYPE: Prospective study

As recreational cannabis use has grown in popularity and accessibility, so have concerns about the risks of cannabis-impaired driving. While we know that cannabis can impair driving performance in a controlled setting (see CATR Jan/Feb/Mar 2023), what about in the real world?

Canada’s nationwide legalization of recreational cannabis in 2018 provided researchers with an opportunity to answer this question. They identified 4,339 drivers treated for moderate injuries from motor vehicle collisions who submitted blood samples as part of their care between 2013 and 2020. Authors divided the drivers into a pre-legalization group (January 2013–September 2018) and a post-legalization group (November 2018–March 2020) and compared THC and alcohol serum levels between them.

The results were eye-opening. The percentage of drivers with THC in their blood nearly doubled after legalization (from 9.2% to 17.9%). The percentage of drivers with a THC level at or above the Canadian legal limit of 2 ng/mL increased from 3.8% to 8.6%, while the percentage of drivers testing at ≥5 ng/mL increased from 1.1% to 3.5%. There was no concomitant increase in the prevalence of drivers testing positive for alcohol. Interestingly, the increase was most pronounced among older drivers (over the age of 50) and male drivers.

There were several limitations to this study. It only included moderately injured drivers, so those with minor injuries or fatal accidents were not accounted for. Additionally, there was variability in the time between the collision and the serum sample, which could impact the accuracy of the THC levels. And although a causative link between cannabis prevalence and injury is plausible, the data in this study remain purely associative.

CARLAT TAKE

This prospective study found that the proportion of moderately injured drivers testing positive for THC increased after the passage of a recreational cannabis law. Patients are aware of the dangers while driving under the influence of alcohol, but this study suggests that you should advise your patients to avoid driving after using cannabis as well.

Addiction Treatment Research Update
KEYWORDS addiction cannabis driving marijuana
    Garrett Rossi, MD.

    A Psychedelic Primer

    More from this author
    www.thecarlatreport.com
    Issue Date: July 1, 2024
    SUBSCRIBE NOW
    Table Of Contents
    Learning Objectives, Forensic Topics in Addiction, CATR, July/August/September 2024
    A Clinician’s Guide to Drug Courts
    Pregnancy, Addiction, and the Law
    Opioid Use Disorder in Correctional Facilities
    Drug Testing and the Legal System
    Buprenorphine Versus Methadone for Opioid Use Disorder in Pregnancy
    Does Cannabis Legalization Increase the Risk of Driving-Related Injury?
    Daily Alcohol Intake and Risk for All-Cause Mortality
    CME Post-Test, Forensic Topics in Addiction, CATR, July/August/September 2024
    DOWNLOAD NOW
    Featured Book
    • OUDFB1e_Cover_Binding.png

      Treating Opioid Use Disorder—A Fact Book (2024)

      All the tools you need to assess and treat patients struggling with opioid use disorder. 
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.